(Q42488567)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Immune regulation of canine tumour and macrophage PD-L1 expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

G Hartley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

E Faulhaber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

A Caldwell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

J Coy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

J Kurihara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

A Guth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

S Dow

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

4 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

Veterinary and Comparative Oncology

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

534-549

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

7 March 2020

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer

21 January 2018

1 reference

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

21 January 2018

1 reference

PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients

21 January 2018

1 reference

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

21 January 2018

1 reference

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

Tumor-associated macrophages as major players in the tumor microenvironment

21 January 2018

1 reference

21 January 2018

1 reference

B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells

21 January 2018

1 reference

Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.

21 January 2018

1 reference

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

21 January 2018

1 reference

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

21 January 2018

1 reference

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

21 January 2018

1 reference

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

21 January 2018

1 reference

Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer.

21 January 2018

1 reference

Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma

21 January 2018

1 reference

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

21 January 2018

1 reference

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 January 2018

1 reference

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

21 January 2018

1 reference

A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells

21 January 2018

1 reference

Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes.

21 January 2018

1 reference

Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells

21 January 2018

1 reference

IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.

21 January 2018

1 reference

The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine

21 January 2018

1 reference

TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.

21 January 2018

1 reference

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.

21 January 2018

1 reference

Expression of PD-L1 on canine tumor cells and enhancement of IFN-γ production from tumor-infiltrating cells by PD-L1 blockade

21 January 2018

1 reference

Polymerase chain reaction-based species verification and microsatellite analysis for canine cell line validation

21 January 2018

1 reference

Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation

21 January 2018

1 reference

Expression of programmed death 1 ligands by murine T cells and APC

21 January 2018

1 reference

Immune response regulation in the tumor microenvironment by hypoxia.

21 January 2018

1 reference

Critical roles of the WASP N-terminal domain and Btk in LPS-induced inflammatory response in macrophages

21 January 2018

1 reference

Anti-WASP intrabodies inhibit inflammatory responses induced by Toll-like receptors 3, 7, and 9, in macrophages

21 January 2018

1 reference

TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cells.

21 January 2018

1 reference

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).

21 January 2018

1 reference

Anti-inflammatory properties of pro-inflammatory interferon-gamma

21 January 2018

1 reference

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

21 January 2018

1 reference

PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials

21 January 2018

1 reference

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/J.1460-2075.1992.TB05481.X

Identifiers

DOI

10.1111/VCO.12197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842912%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference